BIOTHERAPEUTICS
Introduction
The Biotherapeutics Committee works together to increase global access to critical protein-based therapies by encouraging science-based solutions and supporting access to venues where scientists can meet and discuss challenges and potential opportunities for global alignment.
Goals & Objectives
Identify and provide opportunities for researchers, industry, and regulators to address long standing and emerging issues which affect global access to biotherapeutics.
Provide organizational support for meetings where leaders can openly discuss challenges and share information, leading to potential solutions or sparking
innovation.
Engage leaders working in the biopharmaceutical field and health care such that the paths to achieve common goals are well articulated and can be realized.
Encourage innovation and forward-thinking solutions.
Members
Shawn NOVICK
Chair, consultant
Tim SCHOFIELD
CMS Sciences
Barbara RELLAHAN
Amgen
Annie STRUGESS
BMS
Robert MATALIANO
Genzyme
Elaine GRAY
NIBSC
Madhu SILUVERA
Merck
Melody GOSSAGE
Lilly
T. LUBINIECKI
IABS
Michael TARLOV
NIST
Ned MOZIER
Pfizer
Kris BARNTHOUSE
JnJ
Brendan HUGHES
BMS
Frank LI
Catalent
Priorities & Initiatives
Conferences and Workshop planning
In 2019, 2nd Specifications Workshop and the 5th annual statistics workshop (merged) : “Setting specifications for biological products: A pathway to harmonization”
2020 : 6th Annual Statistics Workshop
In 2021, the Biotherapeutics committee is currently in the planning stages for 2 conferences and a webinar.
- 7th annual statistics conference : Quality by design and leveraging platform knowledge, November 8-11
- The 3rd workshop on Global Harmonization of Specifications, Date Q4, 2021 TBD
- A webinar on FMT (Fecal microbial transplantation), May 21 2021
To review IABS Biotherapeutics committee and workshops, click on the button below.
